Research Topics
| P KindSummaryAffiliation: University of York Country: UK Publications
| Collaborators
|
Detail Information
Publications
Re-scaling social preference data: implications for modellingIrina Cleemput
Belgian Knowledge Centre for Health Care, Brussels, Belgium
Eur J Health Econ 5:290-8. 2004..Further analysis, on other data samples, will have to confirm the current findings...- Size matters: EQ-5D in transitionPaul Kind
Med Care 45:809-11. 2007 - Population health status in China: EQ-5D results, by age, sex and socio-economic status, from the National Health Services Survey 2008Sun Sun
Department of Learning, Informatics, Management and Ethics, Medical Management Centre, Karolinska Institutet, Nobels väg 15a, 171 77 Stockholm, Sweden
Qual Life Res 20:309-20. 2011..To measure and analyse national EQ-5D data and to provide norms for the Chinese general population by age, sex, educational level, income and employment status... - Usefulness of EQ-5D in assessing health status in primary care patients with major depressive disorderChristophe Sapin
Altipharm, Paris, France
Health Qual Life Outcomes 2:20. 2004..The present study describes the impact of MDD on patients' HRQL and examines preference-based health state differences by patient features and clinical characteristics... - Eliciting social preference weights for Functional Assessment of Cancer Therapy-Lung health statesPaul Kind
Outcomes Research Group, Centre for Health Economics, Alcuin College, University of York, UK
Pharmacoeconomics 23:1143-53. 2005..The Functional Assessment of Cancer Therapy-Lung (FACT-L) is a multidimensional measure of quality of life developed for use in the evaluation of interventions in lung cancer... - Variations in population health status: results from a United Kingdom national questionnaire surveyP Kind
Centre for Health Economics, University of York
BMJ 316:736-41. 1998..To measure the health of a representative sample of the population of the United Kingdom by using the EuroQoL EQ-5D questionnaire... - Measuring health status: information for primary care decision makingPaul Kind
Outcomes Research Group, Centre for Health Economics, University of York, York YO1 5DD, UK
Health Policy 71:303-13. 2005..This knowledge can also be used by PCTs and other primary care organisations, to better target scarce health resources... - Measuring quality of life in evaluating clinical interventions: an overviewP Kind
Centre for Health Economics, University of York, England
Ann Med 33:323-7. 2001..These values should not be restricted to the private judgement of the clinician alone. The challenge for those evaluating clinical interventions is to make such values explicit and to extend the franchise to society as a whole... - "Death" and the valuation of health-related quality of lifeS Macran
Center for Health Economics, University of York, Helsington, York, United Kingdom
Med Care 39:217-27. 2001..The authors stress the need for more systematic inquiry in this field... - Problems of behaviour, reading and arithmetic: assessments of comorbidity using the Strengths and Difficulties QuestionnaireJ W Adams
Psychology Department, University of York, Heslington, UK
Br J Educ Psychol 69:571-85. 1999..Estimates of academic underachievement among school children vary widely, depending on the geographical location and on the criteria used to define attainment... - The effect of health state selection on the valuation of EQ-5DLing Hsiang Chuang
Outcomes Research Group, Centre for Health Economics, University of York, York, UK
Med Decis Making 31:186-94. 2011..Many aspects of valuation.. - Converting the SF-12 into the EQ-5D: an empirical comparison of methodologiesLing Hsiang Chuang
Outcomes Research Group, Centre for Health Economics, University of York, York, UK
Pharmacoeconomics 27:491-505. 2009..However, there has been no consensus with regard to a regression method that should be recommended for such a mapping task... - Measuring population health: a comparison of three generic health status measuresSusan Macran
Outcomes Research Group, Centre for Health Economics, Alcuin College, University of York, Heslington, United Kingdom
Med Care 41:218-31. 2003..The relative performance of three widely used generic health status measures (EQ-5D, a modified HUI3 [mHUI3], and SF-12) was compared within a general population sample... - Estimating Domestic Values for EQ-5D Health States Using Survey Data From External SourcesLing Hsiang Chuang
Centre for Health Economics, University of York, York, United Kingdom
Med Care 47:168-75. 2009..quot; The general problem faced in the majority of countries where social preferences are required for cost-effectiveness analysis is the absence of a value set based on domestic data sources... - Evaluating podiatry services: testing a treatment specific measure of health statusS Macran
Health Outcomes Group, Centrefor Health Economics, Alcuin College, University of York, Heslington, UK
Qual Life Res 12:177-88. 2003..It is suggested that the respondent completed PHQ appears to be a useful new measure for assessing foot-related health. However, further investigation of the psychometric properties of the measure is required... - The development of a new measure of quality of life for children with congenital cardiac diseaseSusan Macran
Outcomes Research Group, Centre for Health Economics, United Kingdom
Cardiol Young 16:165-72. 2006..Initial findings suggest that it is a valid and reliable instrument, is acceptable to respondents, and is simple to administer in both a research and clinical context... - Using standardised measures of health-related quality of life: critical issues for users and developersPaul Kind
Outcomes Research Group, Centre for Health Economics, University of York, UK
Qual Life Res 12:519-21; discussion 523-5. 2003 - Quality of life assessment of growth hormone deficiency in adults (QoL-AGHDA): comparison of normative reference data for the general population of England and Wales with results for adult hypopituitary patients with growth hormone deficiencyMaria Kołtowska-Häggström
KIGS KIMS ACROSTUDY Medical Outcomes, Endocrine Care, Pfizer, Stockholm, Sweden
Horm Res 64:46-54. 2005..The objective of this study was to develop such data for the QoL-AGHDA instrument for the population of England and Wales and to demonstrate the QoL deficit in patients with GHD... - Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?Maria Koltowska-Haggstrom
KIGS KIMS ACROSTUDY Medical Outcomes, Endocrine Care, Pfizer, Sollentuna, Sweden
Eur J Endocrinol 155:109-19. 2006..To determine whether impaired quality of life (QoL) in adults with GH deficiency (GHD) is reversible with long-term GH therapy and whether the responses in QoL dimensions differ from each other... - US FDA guidance: apropos of PROsPaul Kind
Pharmacoeconomics 24:833-6. 2006 - US norms for six generic health-related quality-of-life indexes from the National Health Measurement studyDennis G Fryback
Department of Population Health Sciences, University of Wisconsin Madison, Madison, Wisconsin 53726, USA
Med Care 45:1162-70. 2007..A number of indexes measuring self-reported generic health-related quality-of-life (HRQoL) using preference-weighted scoring are used widely in population surveys and clinical studies in the United States... - Valuations of EQ-5D health states: are the United States and United Kingdom different?Jeffrey A Johnson
Institute of Health Economics and University of Alberta, Edmonton, Alberta, Canada
Med Care 43:221-8. 2005..Therefore, EQ-5D index scores generated using valuations from the US general population should be used for studies aiming to reflect health state preferences of the US general public... - Logical inconsistencies in survey respondents' health state valuations -- a methodological challenge for estimating social tariffsNancy J Devlin
King s Fund, London, UK
Health Econ 12:529-44. 2003....